National Comprehensive Cancer Network



About NCCN

NCCN Foundation Awards Grants to Six Young Investigators

The NCCN Foundation has awarded its sixth series of Young Investigator Awards to six oncology researchers from NCCN Member Institutions; the awards provide grants of $150,000 over a two-year period for research initiatives focused on assessing and improving outcomes in cancer care. 

FORT WASHINGTON, PA — The NCCN Foundation® has awarded grants to six young investigators from NCCN Member Institutions. These awardees, who are dedicated to advancing and discovering new treatments for cancer, enhancing quality, and improving patient education, represent the sixth series of NCCN Foundation Young Investigator Awards—a program initiated in 2011. The grants will provide $150,000 in funding over a two-year period, beginning in July 2016.

“NCCN Foundation is committed to advancing cancer treatment by funding promising young researchers at the forefront of innovation in cancer research. We congratulate and applaud the 2016 awardees for their dedication to advancing the standard of cancer care,” said Marcie R. Reeder, MPH, Executive Director, NCCN Foundation.

Following are the 2016 NCCN Foundation Young Investigator Awards recipients:

Eli Diamond, MD, MPhil

Ryan Nipp, MD

Elias Obeid, MD, MPH

Saul Priceman,  PhD

Kathryn Ruddy, MD

Daniel Sherbenou, MD, PhD


The awardees responded to a Request for Proposals issued by the NCCN Foundation to the NCCN Member Institutions and were nominated by their institutions. All submissions were reviewed by a multidisciplinary panel of oncology experts; the awardees were selected based on several key components, including scientific merit and study design.  The studies will be managed and overseen by the NCCN Oncology Research Program (ORP).

 “NCCN believes that investments in young investigators at the beginning of their careers is a powerful mechanism to ensure that the best and brightest begin their journey to a future in cancer research,” said Robert C. Young, MD, Interim Vice President, NCCN ORP.

Since their inception in 2011, NCCN Foundation has provided funding to 29 U.S. researchers through the Young Investigator Awards. On March 31, and April 1, 2016, the National Comprehensive Cancer Network® (NCCN®) featured abstracts from the fourth series of Young Investigator Awards recipients during the NCCN 21st Annual Conference General Poster Session in Hollywood, Florida.

The 2016 NCCN Foundation Young Investigator Awards were made possible through support from AbbVie, Inc.; Amgen, Inc.; Celgene Corporation; Genentech, Inc.; Gilead Sciences Inc.; Pfizer, Inc.; and Takeda Oncology.

For more information about the NCCN Young Investigator Awards, visit NCCNFoundation.org.

###

About NCCN Foundation

Through philanthropy, the NCCN Foundation® empowers people through knowledge and advances the mission of NCCN to improve the quality, effectiveness, and efficiency of cancer care, so that patients can live better lives. Visit NCCNFoundation.org.

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives. For more information, visit NCCN.org.

The NCCN Member Institutions are:

  • Fred & Pamela Buffett Cancer Center
  • Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute
  • City of Hope Comprehensive Cancer Center
  • Dana-Farber/Brigham and Women's Cancer Center | Massachusetts General Hospital Cancer Center
  • Duke Cancer Institute
  • Fox Chase Cancer Center
  • Huntsman Cancer Institute at the University of Utah
  • Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Mayo Clinic Cancer Center
  • Memorial Sloan Kettering Cancer Center
  • Moffitt Cancer Center
  • The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
  • Roswell Park Cancer Institute
  • Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
  • St. Jude Children's Research Hospital/The University of Tennessee Health Science Center
  • Stanford Cancer Institute
  • University of Alabama at Birmingham Comprehensive Cancer Center
  • UC San Diego Moores Cancer Center
  • UCSF Helen Diller Family Comprehensive Cancer Center
  • University of Colorado Cancer Center
  • University of Michigan Comprehensive Cancer Center
  • The University of Texas MD Anderson Cancer Center
  • University of Wisconsin Carbone Cancer Center
  • Vanderbilt-Ingram Cancer Center
  • Yale Cancer Center/Smilow Cancer Hospital